← Back to Clinical Trials
Recruiting NCT07205614

NCT07205614 The Good Pain Consultation in Endometriosis.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07205614
Status Recruiting
Phase
Sponsor Sorlandet Hospital HF
Condition Pelvic Pain Syndrome
Study Type INTERVENTIONAL
Enrollment 110 participants
Start Date 2025-11-01
Primary Completion 2027-06-01

Eligibility & Interventions

Sex Female only
Min Age 16 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
pain consultation, biopsychosocial pain education + usual careUsual Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 110 participants in total. It began in 2025-11-01 with a primary completion date of 2027-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This PhD project investigates the effect of "the good pain consultation" and early integration of biopsychosocial pain education with current standard management of endometriosis. Our goal is to facilitate self-management of pain and improve health-related quality of life (HRQOL) using limited resources. Our research question is: Does a good pain consultation improve pain self-efficacy and HRQOL, compared to usual care at 3 months and 1 year.? Researchers will compare a good pain consultation to a control group that will receive usual care. Participants will: Attend a consultation and biopsychososial pain education plus usual care or usual care alone. They will answer questions in an internet-based questionnaires three times point during the study.

Eligibility Criteria

Inclusion Criteria: * biological women Exclusion Criteria: * not speaking norwegian

Contact & Investigator

Central Contact

Inger Johanne W Hansen, MD

✉ inger.johanne.hansen@sshf.no

📞 +47 38149424

Frequently Asked Questions

Who can join the NCT07205614 clinical trial?

This trial is open to female participants only, aged 16 Years or older, up to 50 Years, studying Pelvic Pain Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07205614 currently recruiting?

Yes, NCT07205614 is actively recruiting participants. Contact the research team at inger.johanne.hansen@sshf.no for enrollment information.

Where is the NCT07205614 trial being conducted?

This trial is being conducted at Kristiansand, Norway.

Who is sponsoring the NCT07205614 clinical trial?

NCT07205614 is sponsored by Sorlandet Hospital HF. The trial plans to enroll 110 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology